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THE PRESSURE - THICKENING LOOP: A POTENTIAL APPROACH TO THE
ASSESSMENT OF TRANSMURAL MYOCARDIAL WORK. Mitchell Todd Saltzberg,
Lawrence Young, Qing Xin Shi, Albert J. Sinusas (Yale University School of
Medicine; Section of Cardiovascular Medicine, Department of Medicine, New
Haven, CT)
Regional myocardial work can be determined from analysis of pressurelength loops derived using implanted paired ultrasonic crystals. A recently
developed epicardial Doppler thickening crystal (DTC) technique offers an
atraumatic means of assessing myocardial thickening at the sub-transmural
(endocardial (EN), midwall (MW) and epicardial (EP)) level. We employed the
DTC technique in 5 open chest dogs subjected to graded dobutamine (DB)(2.5 to
15 ug/kg/min) stress, to determine if the area of transmural (TM) and sub¬
transmural pressure-thickening loops (PTL) provided an index of regional
work. Sub-transmural PTL were generated in the left anterior descending
(LAD) perfusion territory and correlated with sub-transmural LAD
microsphere flow, cardiac output (CO), hemodynamic indices of myocardial
work (rate-pressure product (RPP) and maximal dP/dt (dP/dt)), and regional
oxygen consumption (MVO2). MVO2 was determined from analysis of paired
arterial and great cardiac vein blood samples.

DB (10 ug/kg/min) caused an

increase in; TM flow (baseline(B): 0.97+/-0.1 4 ml/min/gm; DB: 2.08+/-0.47
ml/min/gm), TM % thickening fraction (%TF) (B: 1 6.71 +/-3.4 %; DB: 27.7+/1.8%), CO (B: 2.5+/-0.3 1/min; DB: 4.5+/-0.6 1/min), RPP (B: 14941 + /-2 1 5 1; DB:
25377+/-1032), dP/dt (B: 1800+/-329; DB: 4614+/-731) and MVO2 (B: 10.7+/-2.4
ml 02/min/100 gm; DB: 13.3+/-0.8 ml 02/min/100 gm). The serial changes in
the area of the LAD TM PTL correlated with the changes in TM flow (r=0.63,
p<.05), RPP (r=0.65, p<.0 1), dP/dt (r=0.8 1, p<.0 1), and regional MVO2 (r=0.52,
p<.05). Changes in LAD TM flow also significantly correlated with changes in
RPP (r=0.9 1, p<.0 1), dP/dt (r=0.86, p<.01) and regional MVO2 (r=0.89, p<.0 1),
supporting the use of sub-transmural flow as an indirect index of sub¬
transmural work. The changes in LAD sub-transmural PTL area significantly
correlated with flow changes in the MW (r=0.57, p<.05) and EP (r=0.68, p<.0 1)
but not EN (r=0.26. p=NS) sub-regions.
Thus, regional PTL area correlated with regional flow and accepted
indices of both regional and global work. The correlation of sub-transmural
PTL area with sub-transmural flow suggests that PTL analysis holds promise as
a potential index of changes in sub-transmural myocardial work.
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1
Introduction
Several approaches to the assessment of regional myocardial function
have been taken both clinically and experimentally. A recently developed
Doppler based technique to measure contractile function is thought to be a
more reliable, reproducible and physiologic method to assess regional
function. This approach provides a unique layer by layer assessment of
transmural thickening. The purpose of this thesis is to evaluate the potential
role of a novel methodology for the assessment of regional cardiac work at
multiple levels by examining the relationship between transmural thickening
and left ventricular pressure. We have preliminarily tested this approach to
cardiac work in normal animals under conditions of increased demand. In this
paper, the background which provides the framework from which this
method of analysis was developed as well as potential applications on the
clinical level will be outlined with an emphasis on the methodologies
undertaken.

Clinical Perspective
Accurate clinical risk stratification based on myocardial viability and
function is critical to the proper management of patients with coronary
artery disease. This is especially true in the post myocardial infarction patient
where the need to assess viability is paramount. While infarcted myocardium
is known to be rendered nonfunctional, the consequences of an ischemic
insult to the myocardium insufficient to cause necrosis may still result in a
deterioration in function which may persist for an extended period of time
after the initial insult. This functional deterioration associated with transient
ischemia has been described by several authors as myocardial "stunning" [141. Inherent to this concept of "stunning" is a dissociation in the relationship
between myocardial flow and function. Braunwald first summarized this
concept in 1982 where he described "stunning" as a situation in which:
"An ischemic insult not of sufficient severity or duration to produce
myocardial necrosis may acutely affect myocardial repolarization and
cause angina (hit); but these changes wane rapidly (run), when the
balance between myocardial oxygen supply and demand has been
reestablished. However, the ischemia may interfere with normal
myocardial function, biochemical processes and ultrastructure for
prolonged periods (stun).[11"
The duration of myocardial dysfunction is directly related to the
duration of the initial ischemic insult. From the clinical standpoint, several
authors have described the delayed recovery of cardiac function either after
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thrombolytic therapy [5-7] or during and after percutaneous transluminal
coronary angioplasty (PTCA) [8] to support the clinical existence of
"stunning". From the experimental standpoint, data exist which demonstrate
that periods of brief (less than 20 minutes) experimental coronary occlusion
result in a functional deficit which only gradually resolves, taking from
several hours to several days to fully recover depending on the duration of the
initial insult [9],
Another concept that has both clinical and experimental support is that
of "hibernating myocardium." This term was first introduced by Rahimtoola
in his 1985 summary of data from three large multicenter randomized clinical
trials of coronary artery bypass grafting (CABG) surgery for chronic stable
angina [10]. This term was introduced to describe the situation in which:
"...there is a prolonged subacute or chronic stage of myocardial
ischemia that is frequently not accompanied by pain and in which
myocardial contractility and metabolism and ventricular function are
reduced to match the reduced blood supply."
In contrast to the concept of "stunning", hibernation is thought to
represent a balance between flow and function. Bristow proposed that
myocardial ischemia is a regulated process which serves "...to protect the
anatomic and physiologic integrity of the cardiac cell" through a downregulation of function and re-establishment of a metabolic balance [11], Ross
extended this concept when he emphasized the role of regional, as opposed to
global ischemia in describing how flow and function are highly coordinated
[12].

Clinical examples have served to illustrate this phenomenon in patients

who are either post-CABG in whom functional recovery occurs with
revascularization [131, or who demonstrate enhanced myocardial function
with inotropic stimulation despite the presence of flow-limiting coronary
stenoses (i.e. contractile reserve phenomenon) [14], Although experimental
models of myocardial stunning have been easy to generate, developing models
of hibernation has proven more difficult. Models by Matsuzaki and Edwards
using the in vivo doe heart [15, 16] and Liedtke using the extracorporeally
perfused pig heart [17] have approached hibernation by looking at the flow
function relationship in response to short-term reductions in coronary
perfusion.
Need to Asse-saJunction
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Central to the concepts of both "stunning" and "hibernation" is the
assessment of cardiac function. Determination of function can be divided into
(1) measures of global function and (2) measures of more regional function.
Measures of purely global function center around the hemodynamic
performance of the heart. One of the most basic measures of global function is
the maintenance of forward flow of blood through the heart into the great
arteries. This is typically measured as the cardiac output expressed as (liters of
blood)/minute or cardiac index (l/min/m^), which is the cardiac output
corrected for the surface area of the individual. A second global index of
cardiac function is the stroke volume, which is the difference in ventricular
blood volume between end-diastole and end-systole. A third related measure of
global ventricular function is the ejection fraction of the ventricle, defined as
the stroke volume divided by the end-diastolic volume.

These load dependent

measures of function are not capable of providing information about
ventricular function at the regional level since they represent the total
efforts of all portions of the ventricular chamber.
Methods which assess both global and regional function, are also
available. First, the use of echocardiography (ECHO) in the clinical and
experimental setting to assess function has provided valuable information
regarding (1) global performance as assessed by the ejection fraction, (2)
regional wall motion, and (3) wall thickening [18-20], This technique is
advantageous because it is non-invasive, relatively inexpensive and
expeditious. Second, equilibrium and first pass radionuclide ventriculography
(RVG) at rest and with exercise is useful for both the detection of regional and
global wall motion abnormalities and determination of left ventricular
ejection fraction with increased reproducibility over ECHO. Finally, the use of
left ventricular contrast angiography to assess wall motion provides yet
another means to assess left ventricular function.
On the forefront of cardiac imaging today is the use of either (1) gated
magnetic resonance imaging for the high resolution detection and tracking of
regional wall motion and (2) cine-computed tomography which also provides
for high resolution detection of regional wall motion and chamber volumes
with the caveat of radiation exposure to the patient [21].
Inotropic Manipulation of Function

Inotropic stimulation in conjunction with analysis of regional or global
function has been useful for the estimation of myocardial viability. Inotropic

agents (e.g. isoproterenol(ISO) and dopamine (DOPA)) have as their primary
route of action, stimulation of beta-1 receptors in the heart. These receptors
modulate the contractile and chronotropic state of the heart [22]. The use of
these inotropic agents has proven to be most useful clinically to not only
maximize cardiac function in a variety of settings, but also as a diagnostic tool
to detect the presence of contractile reserve as a marker a cardiac viability [14,
23-251.
Further work in the experimental setting has examined the role of
either ISO or DOPA stimulation in the setting of experimental "stunning" [2628], and low-flow ischemia [25, 29, 30],

In these experimental settings

however, inotropic stimulation (ISO>>>DOPA) was occasionally found to
paradoxically depress perfusion and function in an area distal to critical
coronary stenosis, presumably due to the induction of ischemia potentially
related to the strong chronotropic effects of these agents. Inotropic agents
have since been modified to provide the maximal inotropic stimulus while
attempting to avoid the chronotropic, arrythmogenic, and vascular properties.
In 1975, Tuttle an Mills introduced dobutamine (DOB), which had been
chemically derived form isoproterenol [31]. Dobutamine has since found its
way into a number of clinical uses, including: (1) the setting of acute
myocardial infarction to improve or maintain adequate cardiac function [32,
33] (2) the setting of chronic progressive coronary disease and heart failure
[23, 34, 35] and (3) the setting of non-invasive cardiac imaging with ECHO and
or nuclear cardiac scanning to detect ischemia and/or assess viability [36-38,
99], In contrast to ISO , in experimental models of infarction and "stunning",
DOB has been found to consistently augment function in ischemic regions [25,
30, 39-41] . Thus, it is felt that dobutamine may be the preferable inotropic
agent to maintain function and, when used in conjunction with various
cardiac imaging procedures, provide useful diagnostic information.
Experimental Approaches to Function
There exists experimental approaches to function which permit a
higher resolution approach to cardiac function than techniques discussed
thus far. Among the most widely applied of these techniques are (1) the use of
two paired ultrasonic crystals to examine wall thickening and/or segment
shortening and (2) the use of a single epicardial Doppler crystal technique to
obtain wall thickening data.
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The ultrasonic two-crystal technique measures dimension by sensing
the time required for a sound pulse, which is generated by one of the
transducing crystals, to traverse the medium (myocardium) in which it is
applied, and be received by the second crystal. To sense the distance between
the two crystals, the time required for the sound pulse to travel from one
crystal to the other is divided by the speed of sound through the intervening
tissue (i.e. x(dist) = (transit - time)/{transit - speed)).

This technique can be

applied in one of two ways. First, both crystals can be implanted at the same
depth in the myocardial wall along any of the cardiac axes to measure segment
length changes during the cardiac cycle. Second, it is can be used to measure
wall thickening at any depth of the myocardial wall by simply placing one of
the crystals at a given depth in the myocardial wall, and placing the other on
the epicardial surface. Thus, any displacement which takes place across
between the two crystals during the cardiac cycle will represent the change
in wall thickness. The potential advantages of this technique lie in its ability
to detect (1) absolute distances of either segment length or wall thickening
and (2) measures of wall thickening at multiple regional locations at the same
time. The disadvantages of the two crystal technique are: First, to function
correctly, the crystals must be properly aligned to achieve optimal signal
transmission and reception. Second, the implantation of the crystals, up to 2
mm in diameter is traumatic to the cardiac wall and may distort the local fibers
in such a way as to make measurements on absolute dimension unreliable [42],
A more recently developed technique to assess myocardial thickening is
based on the pulse-echo mode of operation common to the two crystal method
described above. This method, however, uses a single epicardial crystal,
functioning as both transmitter and receiver by means of an adaptation of the
pulsed Doppler theory of operation originally applied to sense blood flow
velocity. The Doppler effect is based on the fact that "When an emitted sound
beam is reflected from a moving target to a stationary receiver, the frequency
of the received echo signal if different from the frequency of the original
emitted signal" (i.e. the frequency is Doppler shifted) [43], The single
epicardial based crystal has a variable "range-gated sample volume" which
allows the operator to sample the Doppler shift produced at any layer across
the myocardial wall.
By (1) measuring this Doppler shift in frequency produced by the
movement of myocardial layers passing back and forth through the range
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gated sample volume, and (2) keeping track of the direction and motion of
these displacements and integrating the velocity of movement, one can
reconstruct the displacement of myocardial layers at the preset sample depth.
The advantages of this technique are multiple. (1) The crystal is applied
without trauma to the myocardial wall, only three to five superficial sutures
being required to secure it. (2) No alignment is required with a second
transducing crystal. (3) Ease of application is greater since only one crystal
need be applied. (4) Perhaps most importantly, this technique allows for the
range-gated sample volume to be advanced stepwise across the myocardial wall
to measure wall thickening discretely at various depths. It is this application
of the technique which is being utilized in this thesis project to allow for the
measurement of cardiac work on a sub-transmural basis.
The major disadvantage of the technique is the fact that, in contrast to
the two crystal method, the absolute displacement in millimeters cannot be
determined since only dynamic changes in wall velocity are being measured.
This technique has been validated against the two crystal technique by
placing the Doppler crystal on the epicardial surface of the heart and
positioning a standard ultrasonic crystal within the myocardial wall opposite
the first crystal. The intra-myocardial crystal was then connected to a module
designed to receive the Doppler pulse emitted by the epicardial crystal. Thus,
simultaneous measurements could be obtained via either (1) the single
epicardial crystal method or (2) by the two crystal method using the same
epicardial crystal this time, however, as the transmitter in a dual crystal setup.
The waveforms and calculated thickening fractions were found to compare
favorably between the two methods under conditions of normal perfusion and
cardiac ischemia [42, 44].
This Doppler based method has since been applied experimentally to a
model of "stunned" myocardium [45, 46] and clinically to monitor cardiac
function in patients who are undergoing cardiac surgery [47], The successful
use of this technique to assess thickening in these situations indicates the
value of this method in both the clinical and experimental setting.
Assessment of Transmural Function
One of the key applications of the above techniques has been the
examination of the contractile function across the myocardial wall. Sabbah
was first able to demonstrate using the two crystal technique that the inner
half of the myocardial wall undergoes substantially more thickening (" 4:1)

than the outer half of the wall [48]. When Hartley first proposed the Doppler
based method, he suggested that thickening was actually uniform across the
myocardial wall [42]. However, later work by Zhu et al. using the same Doppler
technique came to the conclusion that contractile function was in fact,
nonuniform, with the endocardium thickening to a greater extent than more
superficial layers [44]. This transmural gradient in contractile function has
been supported by other authors using either the two crystal transit time
technique [49, 50] or pulsed Doppler epicardial crystal technique [16]. It was
demonstrated that under conditions of non-transmural ischemia produced by
partial coronary occlusion, a dissociation of myocardial flow and function may
occur in the epicardium [16]. This type of transmural analysis of function has
given new insight into the contractile process with the promise of providing a
better understanding of how contractility is regulated under changing
conditions of supply and demand.
Importance of Flow
To fully address the concept of transmural function, one needs to discuss
the role, regulation, and distribution of myocardial perfusion. On the simplest
level of understanding, function cannot be sustained in the absence of blood
flow. In the case of the in vivo working heart, this blood flow requirement is
quite substantial. For an organ which weighs about 0.2% of body weight, it
uses about 4.0% of the total body oxygen consumption which it extracts at a
rate of 65-85% from the blood which passes through it [5 11. To maintain this
tremendous demand for blood, the coronary circulation has an elaborate
system of autoregulation whose ultimate goal is to maintain perfusion under a
wide range of conditions in sufficient quantity to provide the oxygen required
for normal cardiac function despite wide variations in demand. The inotropic
agents, which are known to augment function and therefore demand, have
been shown to produce parallel increases in perfusion across the ventricular
wall as myocardial work and oxygen consumption increase, as long as
coronary autoregulation is intact [51].
Methodoloeic Approaches to Flow
The documentation of myocardial flow in the laboratory setting has
been extensively studied. It has now become a standard practice to assess
myocardial flow using the radioactive microsphere method first proposed by
Rudolph and Heymann [52], Briefly, this method involves the injection of a
suspension of radiolabeled particles into the left atrium, to ensure adequate

mixing with blood, while simultaneously withdrawing a reference sample
from the peripheral circulation. The reference sample is drawn at a known
and constant rate. By subsequently comparing the counts in the reference
sample with the counts in the myocardial sample, the myocardial flow can be
determined. It has been shown that the microspheres are trapped in the small
terminal vessels in the myocardium where they remain fixed without
disturbing the native circulation. Furthermore, the microspheres are
distributed to all organs in proportion to the regional blood flow that they
receive [53, 54],
Markers of Function
The role of transmural perfusion and function has been extensively
studied in a wide variety of experimental settings. In 1963, several articles
were published which looked at the oxygen consumption, as an independent
marker of myocardial work, and global coronary blood flow in a variety of
canine models. The results of these experiments were indeterminate, as some
investigators documented parallel changes in oxygen utilization with changes
in coronary blood flow [55-57], while others did not [58, 59], Work by Daniell
in a canine model looked at the role of global flow reductions on both oxygen
consumption and contractile force as measured with an epicardial strain
gauge. This study reported a significant correlation between the coronary
flow and both contractile force and oxygen consumption [60].
Later work by other investigators looked at the relationship between
wall thickening as a marker of function and transmural flow was able to
discern that more specifically, the blood flow to the endocardium correlates
best with transmural function [16, 61-651. These studies provide evidence that,
while flow and function may be closely matched under normal conditions,
regional dissociation between these two variables may exist when examined
transmurally under conditions of ischemia.
Pressure-Volume Analysis
A third line of investigation into functional markers began with Suga
in 1980 [66] with the use of the area traced by an X-Y plot of changing left
ventricular pressure vs. changing left ventricular volume (P-V
DiagramMFigure 1). The pressure-volume area (PVA) inscribed by this
diagram represents the total mechanical energy generated by a cardiac
contraction. This includes both external work the heart does to generate
forward movement of blood and potential energy which is stored as elastic
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energy in the ventricular wall [67], This potential energy can be used to
contribute to the mechanical work under certain conditions [68], The
external mechanical work that the ventricle performs during a contraction is
represented by the area inscribed by the counter-clockwise rotating lines of
isovolumetric contraction/relaxation phases and the ejection/filling phases of
the cardiac cycle (67). The initial and subsequent studies were able to
demonstrate that the PVA was linearly related to the oxygen consumption of
the left ventricle under a variety of conditions [67, 69, 70).
Further analysis of the pressure-volume relationship revealed that by
tracking the end systolic point in the P-V diagram under different loading and
contractility conditions, a relation could be derived which was called
appropriately, the End-Systolic Pressure Volume Line whose slope, (Emax). was
found to be a powerful index of contractility [67, 69], The use of various endsystolic based indexes have since been applied in different experimental
settings for comparison. These include the development of end-systolic
pressure-length [71,72], left ventricular dimension-wall thickness [731 and
stress-strain indexes [72], The above indexes have been found to be
comparable under most conditions for the accurate assessment of contractility.
Pre.&s.urg=Leneth Analysis
The use of the PVA to measure cardiac work and predict oxygen
utilization can only serve as a global index since it depends on the pressure
and volume within the ventricular cavity. It fails to provide independent
information about function and work at the regional level. The earliest
attempts to assess regional function via loop analysis came with Tyberg in 1973
with the development of the clockwise rotating pressure-length loop
generated using an epicardial mercury-filled silastic length gauge [74, 751.
Their analysis concluded that the area inscribed by this loop represented the
mechanical work produced by a given cardiac segment during the cardiac
cycle. Furthermore, by analyzing the morphometries of these loops under
ischemic conditions, information could be derived about the temporal
sequence of contraction at various regions in the heart . The onset of ischemia
was heralded by systolic lengthening with a sharp decline in the area of the
pressure-length loop and actually reversal of the rotation of the loop. With
severe ischemia, the ischemic segment was found to stretch passively during
ventricular systole, providing evidence that the energy generated by the non-

ischemic segments was being dissipated into the ischemic segment (See Figure
2) [751.
A more recent investigation by Vinten-Johansen examined the
relationship between the MV02, transmural segmental work and segment
shortening (SS) after repetitive occlusion-reperfusion periods in the dog
using the pressure-length loop. These authors noted a sharp decline in SS and
pressure-length loop area with LAD occlusion, although a positive loop area
(i.e. positive segmental work) was still generated despite akinesis and even
dyskinesis in the segment. In addition, the MVO2 declined but did not go to zero
despite the profound changes in SS. These findings were taken as evidence
that the discrepancy between SS and MVO2 is partially due to the persistent
development of segment work by the ischemic segment [76].
In 1991, Safwat et al. generated pressure-length loops using the two
crystal ultrasonic technique to obtain their segment length data. In this
analysis, the loops were analyzed with reference to both the end-systolic and
end-diastolic time points (Figure 3). Three distinct periods were delineated
within the loops: these were (1) the effective shortening area (ESA)
occurring during systole (2) the post systolic shortening (PSS) area and (3)
the segment lengthening area (SLA) occurring in early diastole. They
concluded that only the effective shortening area was sensitive to ischemia,
even more so than the total loop area [77],

A novel clinical application of the

pressure-length loop has also been described whereby changes in segment
length were obtained form left ventriculograms using a radial analysis to
detect centripetal movement of the endocardial surface [78].
In an attempt to overcome the difficulty in measuring segment length
in the clinical setting, Nakano et al. introduced a mathematical means to assess
regional work which incorporates the wall thickness. The equation derived
was RWM -

-J

od[\n{\ / //)] , where <7 = stress as defined by P x D/411,

P=ventricular pressure, D=ventricular diameter and

wall thickness, both of

these dimension parameters being determined by ECHO. This technique has
been validated in an animal model and was shown to reliably provide
information about the regional work in both normal and coronary artery
disease patients.
Hypothesis
Few investigators have thus far been able to relate the three variables
of (1) contractile function, (2) myocardial perfusion and (3) cardiac

metabolism on the regional level with much success. This project was designed
to gain further insight into the regional interrelationship of these variables.
The Doppler based epicardial crystal technique of measuring sub-transmural
myocardial thickening will be employed to generate left ventricular pressurethickening loops as a novel approach to determining regional work. The area
of the pressure-thickening loop will be related to flow, oxygen metabolism,
and hemodynamic parameters of function at the transmural level and then
subsequently at each level of the myocardial wall (i.e. endocardial, midwall,
and epicardial) by relating the changes in work to the changes in flow. It is
hoped that the ability of the Doppler technique to interrogate discrete layers
across the wall will allow for the first time, the assessment of work on a sub¬
transmural basis with both accuracy and reproducibility. We propose to test
this hypothesis in a normal canine model with graded dobutamine stress to
examine work under different levels of inotropic stimulation.

Materials and Methods
Surgical Preparation:
Fasted mongrel dogs of either sex, weighing between 40-50 pounds were
pre-medicated with atropine (0.07 mg/kg) and ketamine (10 mg/kg), then
given by rapid intravenous bolus, sodium thiamylol (20 mg/kg) to induce
rapid anesthesia. The animals were immediately intubated by direct
laryngoscopy and ventilated on a pressure ventilator with a tidal volume of 2025 cc/kg. Anesthesia was maintained with a 70:30 N20:02 mixture with
halothane (.5-1.5 %) to a level at which (1) the eye blink response was
abolished (2) no response was noted with surgical incisions and (3) no
resistance to the function of the ventilator was observed.
The animals, once fully anesthetized were instrumented as follows. The
limb leads of the electrocardiogram were placed to monitor the
electrocardiogram. Bilateral groin dissections were performed to expose both
femoral arteries and one femoral vein. A pair of 8F stiff-walled catheters were
placed in one femoral artery, and a third catheter was placed in the other
artery. An additional catheter was placed in a femoral vein to facilitate fluid
administration. One 8f catheter from each femoral artery was reserved for
arterial withdrawal during the administration of radiolabeled microspheres
for flow, the third being used to monitor systemic pressure. A ventral midline
abdominal incision was made to gain access to the urinary bladder for
subsequent catheterization. The left neck was dissected for isolation of the
external jugular vein and left common carotid artery. An introducer was
placed in the common carotid artery to allow for the retrograde passage of a
high fidelity Millar® micromanometer catheter to a sub-aortic valve position
for measurement of left ventricular pressure and dP/dt. A 6f catheter was
placed retrograde into the coronary sinus via the external jugular vein and a
Swan-Ganz catheter was placed by the same route into the pulmonary artery to
facilitate monitoring of body temperature, right atrial pressure and cardiac
output by the indicator dilution method.
A left thoracotomy was then performed via the fifth intercostal space to
expose the heart. The pericardium was opened and the heart suspended by a
pericardial cradle. The left lung was retracted using an unfolded 4x4 gauze to
facilitate access to the heart. A silastic catheter was placed into the left atrium
via the left atrial appendage for the administration of radiolabeled
microspheres and monitoring of left atrial pressure.

The proximal left anterior descending (LAD) coronary artery was
dissected free, taking care to not disturb any septal branches, above the
bifurcation of the second major diagonal branch to allow for placement of the
Doppler flow probe and snare occluder.
Finally, Doppler thickening crystals were sutured to the epicardial
surface in both of the regions supplied by the LAD and left circumflex
coronary artery (LCX) using three to four 6-0 sutures penetrating the
epicardial surface to a depth of 0.5-1.0 mm.
Theoretical Considerations of Doppler Based Method
As measurement of both proximal LAD flow and myocardial thickening
in this animal preparation are based on the Doppler principle, the theoretical
foundation of this technique will now be addressed.
The Doppler effect, as stated earlier, depends on the change in
frequency of an emitted sound pulse produced by a moving object, which is
detected by a stationary receiver. In the special case where a single
transducer acts as both emitter and receiver, an equation exists which
describes the relation between the velocity of the moving object and its
Doppler shift:
V = (A/ x c) / 2 x fo x (cos a) (equation 1)
Where fo=transmitted frequency (Hz), V=velocity of the reflector (m/sec),
c=speed of sound in the medium (m/s),

cr= angle between the direction of the

emitted sound beam vector and velocity vector of the reflector and
in frequency produced by the moving reflector.
this experiment, the angle

A/=change

For the flow probes used in

a is fixed at 45 degrees by mounting the Doppler

crystal in the silastic and wax housing which fits around the vessel. Since f0 =
20 Hz and the velocity of sound within the vessel is constant at 1500 m/s, then
by substitution equation 1 becomes:
Vmax(cm/sec) = 5.3 x A/(KHz)

(equation 2)

The Doppler flow probe operates by emitting pulsed bursts of sound
separated from one another by 16 usee into the blood vessel where they are
reflected by the moving blood cells and received at a Doppler shifted
frequency back at the probe. A useful means to describe the distance between
transmitted pulses is to use the inverse of the period, commonly referred to as
the Pulse Repetition Frequency (PRF) (i.e. PRF = (.016 sec) "1 = 62.5 KHz). The
time required for the sound echoes to be received is described by the equation:
t = 2 x (d/c ) (equation 3)

Where t = time delay (sec), d = distance between the transducer and the
reflector (m), and c = speed of sound in the medium (1 500 m/sec). The receiver
selectively samples the echoes received from within a "sample volume", which
is a 1 mm^ sensitivity region produced by the crystal. Echoes are sampled for a
period of time whose length is defined by adjusting the "range-gate delay."
For example, adjusting the range gate delay will move the sample volume to
various positions across the vessel wall, thus proportionately changing the
period of time during which echoes are received to allow for selectively
sampling of flow at various vessel positions. The echoes which are received by
the probe are then amplified and compared in phase and frequency to that of
an internal reference oscillator which operates at the acoustic carrier
frequency (f0) of 20 MHz. The 20 MHz acoustic frequency chosen for this
system, has been found to balance the tradeoff between the high acoustic
scattering of blood cells which is proportional to the fourth power of
frequency and the acoustic absorption of blood which also increases with
frequency. Further, at 20 MHz the signals reflected from blood are strong
enough to allow for the flow probe to sense velocity at distances from 1-10 mm
from the crystal face, well within the range of normal epicardial vessel
diameters. Since blood flow is typically expressed as ml/min, and not m/sec, a
mathematical means to convert velocity into flow was developed by Hartley
[79], Under ideal conditions, flow is described by the equation:
Q(ml / min) = (Vavg(mm / sec)x Area(mm2))x 60 (equation 4)
Where Vavg = average velocity of flow across the vessel wall. However, since
cross sectional area is not readily determined in vivo, it was determined that
under conditions of laminar flow with a parabolic velocity profile, Vavg =
Vmax/2. By substitution, the flow equation then becomes:
Q(ml I min) / Af(KHz) = (5.3x Area(mm2) / 2 (equation. 5)
By setting the Area = d^/4 where d = internal vessel diameter estimated by the
size of appropriately fitting flow probe, one derives the final equation for
flow:
Q(ml / min) / Af (KHz) = 1.25 x d2 (equation 6)
This method has since been validated with against timed collections of effluent
blood with a strong linear relationship being found to exist.
To ensure proper function of the flow probes, several precautions need
to be taken. First, adequate fit of the flow probe around the vessel ensures that
the angle between the embedded Doppler flow crystal and vessel axis remains
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constant at 45 degrees. Proper fit also ensures that the vessel diameter will be
estimated correctly for use in the velocity to volume calculation. Flow probes
are supplied in 0.5 mm increments with internal diameters of 2.0-3.5 mm.
Second, the sample volume needs to be positioned in the center of the vessel
axis to ensure that maximal blood flow velocity is being sampled. As stated
earlier, assuming conditions of laminar flow with a parabolic velocity profile,
this position is easily determined as that at which the signal obtained has the
greatest amplitude. Third, to avoid deterioration in signal quality from nonlaminar blood flow, the probes need to be placed at the most proximal position
on the vessel, typically proximal to the second major diagonal branch and
snare occluder. The final step to ensure proper function is correct calibration
of the probe by systematically applying a known Doppler shift frequency
from which the flow instrument is able to register the appropriate voltage
reading.
Working from the same theoretical framework as Doppler based flow
measurement, Hartley developed the technique to measure wall thickening
[42]. The Doppler probe consists of a 4 mm disk of 10 MHz piezoelectric crystal
which has been attached to a circular piece of Gortex® graft material, used to
secure the probe to the epicardium. The probe operates much like the flow
probe, by using pulsed sound waves directed perpendicular (

a = 0° from

equation 1) to the myocardial wall to detect the Doppler shift produced by the
movement of various myocardial layers within the sample volume during the
cardiac cycle. The range gated sample volume is adjusted as before to allow for
interrogation of the various layers across the wall, at depths ranging form 240 mm. The crystal operates at an ultrasonic frequency of 10 MHz with a PRF
of 4 KHz (250 usee separation). By comparing the echoes produced by the
myocardium with those of two internal reference oscillators, the phase
difference is used to convert back and forth movement in time into up and
down motion in voltage at the given range delay. In essence, the circuitry
electronically integrates the velocity of myocardial wall movement to
determine displacement.
This method does not depend on the ability to track a discrete interface,
rather, displacement is measured at a fixed depth. Thus, within the sample
volume, the myocardial layers present at any given time change throughout
the cardiac cycle. Layers within the sample volume at end-diastole tend to be
deeper than those seen at end-systole since the wall has thickened. Since no
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layer is tracked, the starting point for the phase detection is arbitrary, thus it
is not possible to measure the absolute thickness, only the relative excursion.
Furthermore, the final output location along the thickening axis, as it appears
on the chart recorder bears no relation to the actual thickness of the wall.
The variable range gate delay is used to set the time delay (3-50 usee) at
which the phase of the signal is sampled. Since the echoes produced by the
myocardium are relatively low frequency when compared to those of blood
flow, the audio echo signals are limited to a band extending from 1 Hz to 1 KHz,
thus allowing velocities from .075 mm/sec to 7.5 cm/sec to be sensed. For
comparison, blood velocities usually range from 1 to 100 cm/sec with an
associated audio band of 100 Hz to 10 KHz [42, 43, 791. The sampled phase
changes are recorded such that movement toward the probe advances an
electronic counter, while movement away subtracts from the counter. The
real time output from the counter is then fed through an analog to digital
converter which produces the final voltage output which is calibrated to a
millimeter displacement. The resolution of the system allows for displacements
as little as .02 mm to be detected.
To measure wall thickening quantitatively, the % thickening fraction
(%TF) of the various myocardial layers is determined. By the classic two
crystal ultrasonic technique, %TF is expressed by the following equation:

((EST — EDT) / EDT) x 100(equation 7)
Where EST = end-systolic thickness and EDT = end-diastolic thickness. In this
preparation, since absolute thickness is not directly possible, a mathematical
means was developed by Hartley [42], By knowing the value of range gate
delay (R) in mm, and the total systolic excursion (SE) of thickening in mm,
%TF is described by the equation:

%TF = (e(SEIR) -1) x 100 (equation 8)
Operation of Doppler Thickening System
As stated earlier, thickening crystals are placed in both the LAD and LCX
territories for the collection of data. The proper range gate delay, is
determined by gradually advancing the range gated sample volume until the
blood pool is detected by a sharp change in the audio signal. The sample
volume is then brought back to a position where the quality of the signal is
consistent throughout the cardiac cycle. The maximal depth that the Doppler
crystal ( as well as the dual crystal ultrasonic crystal technique) is able to
sample thickening at, has been estimated to be 85% of the total wall thickness
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[16,94] . As demonstrated in Figure 4, this depth is considered to represent the
transmural thickening.

The total range is then divided in thirds, thus

allowing signal sampling at two other positions besides the transmural point.
Since the crystal measures thickening between the level of the sample volume
and the crystal itself, the three positions across the myocardial wall will
represent thickening of the: (1) transmural (Tm) or full wall thickness, (2)
outer two-thirds (Out 2/3) of the wall and (3) outer one-third (Out 1/3) of the
wall. To avoid placing the crystals, especially the one situated in the LCX
territory, over a papillary muscle, the range gate at which the blood pool is
encountered is tracked at various positions within the territory. Papillary
muscles are easily determined as positions on the myocardial wall at which the
blood pool location is deeper than expected (e.g. greater than 14 mm). Once the
crystals are positioned correctly, both the range and thickening are
electronically calibrated to ensure appropriate function.

Computer Data Acquisition
All experimental data are recorded using an eight channel computer
based data acquisition program referred to as DATAFLOW (Crystal Biotech,
Holliston MA). The hardware includes a multichannel interface module (VF-1,
Crystal Biotech) whose output is linked through an analog to digital (A/D)
converter to a 486(25 Mhz) Computer (Gateway 2000). An oscilloscope is used to
give a visual representation of the range outputs from both thickening
crystals and the flow probe. Dataflow is able to interpret the digital output of
the A/D converter into the appropriate units and reconstruct the channel
outputs in real time. In addition, Dataflow computes a variety of statistics in
real time for each channel (e.g. mean, max., min, +/- derivatives etc...) (See
Figure 5).
Dataflow collects the data from a total of eight channels during the
course of each experiment: (1) LAD flow output from the 20 MHz pulsed
Doppler module in VF-1 (PD-20; Crystal Biotech) (2) LAD Thickening from the
pulsed Doppler dimension module (DMM-10; Crystal Biotech) (3) Left
Ventricular Pressure (LVP) from the Millar Micromanometer module (Millar
Industries) (4) LAD Thickening Range also from the DMM-10 module (5) ECG
for heart rate from the limb leads of the electrocardiogram (6) Aortic
Pressure for both systolic and mean pressure from a fluid filled pressure
transducer output (7) LCX Thickening from the second DMM-10 on the VF-1
and finally (8) LCX Range from the same module. Dataflow has built in
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derivation of the first derivative of left ventricular pressure (dP/dt) which is
displayed simultaneously with the LVP. All eight channels above are also
directed into an eight channel pen recorder for hard copy record.
Dataflow provides the ability to save large amounts of data in two
different formats during the course of a given experiment. The program is
first able to create a trending file of all channels at user specified intervals of
10-60 sec. Second, the user can perform manual saves to capture up to eight
channels of data at specific time points in the experiment. These data are
stored at intervals of .00221 sec for a total of about 5 seconds to give 300-2400
data points (1500 for this preparation). These manual saves provide the raw
data for subsequent analysis.
Other data not recorded through Dataflow includes: Cardiac Output
using the Swan-Ganz catheter and Cardiac Output computer (Edwards
Laboratories, New York, NY), body core temperature from the Swan-Ganz
catheter, arterial blood gas data every 45-60 min, left and right atrial
pressures and metabolic data for oxygen content.
Myocardial Blood Flow Determination
Regional myocardial blood flow is determined using the radiolabeled
microsphere referenced withdrawal technique introduced by Rudolph &.
Hey man in 1967 (52). Microspheres (12 um diameter), supplied by DuPont were
pre-labeled with the following isotopes: Sn-1 13, Sc-46, Ru-103, Cr-5 1 and Nb95. Prior to injection, the dose of microspheres to be given (average >2
million) are decay corrected to ensure that the radioactivity injected for each
flow determination is comparable. The microspheres are mixed with saline,
vortexed and flushed between two syringes via a three way stopcock to ensure
an even distribution without microsphere aggregates.
Prior to injection of the microspheres, the withdrawal pump connected
to the two 8F femoral artery catheters is started to ensure the smooth return of
blood. Once constant flow is established, the microspheres are injected into
the left atrium over a 15-20 second period, followed by 5 cc of saline as a flush.
The withdrawal pump continues at a constant rate of 5.68 cc/min for 95
seconds providing paired 9 cc samples of blood. Once complete, an additional 3
cc of blood from each catheter is withdrawn to ensure clearance of all
microspheres from the catheter "dead space". It has been shown that no
microspheres remain in the circulation 60 seconds after injection [54].

The 24
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cc of blood is evenly divided among 16 vials and weighed in preparation for
gamma well counting.
Post-mortem the heart is trimmed to separate the ventricles and septum
from the rest of the heart. The ventricles are then divided into five (5) slices
along the short axis from base to apex. The slices are then incubated in a
solution of triphenlytetrazolium chloride (TTC) at 37 °C for 20 minutes to
delineate any necrotic myocardium. The slices are photographed and the
location of the thickening crystals are marked on an acetate template.
The visceral pericardium and any remaining fat are trimmed in
preparation for gamma well counting for the determination of regional blood
flow. The short axis slices are then divided into eight evenly spaced radial
segments, with each segment then being divided into thirds to separate the
endocardium, midwall and epicardium. Each slice is placed in a numbered vial
(1 to 96), weighed and counted in a multichannel gamma well counter (Cobra
Systems). Separation of the activity for each radiolabeled microsphere by
specific energy windows was performed according to the method of Heymann
[54] with the appropriate spill-up and spill-down corrections.
To determine the myocardial blood flow, the following formula was
utilized [52]:

Qm = CmxQref/Crtf (equation 9)
where Qm = myocardial blood flow (ml/min), Cm=radioactivity in myocardial
sample (cpm), Qref=reference withdrawal rate (ml/min) and Cref=radioactivity
in the reference withdrawal sample (cpm). Flow is then corrected for the
weight of each myocardial sample so that final flow is expressed in units of
ml/min/gm.
This technique provides the ability to assess flow at multiple time points
during the course of single experiment. It has been shown that appropriately
sized microspheres are permanently trapped in the microcirculation on the
first pass without causing any hemodynamic compromise [54],
To facilitate the comparison of flow with the pressure thickening loops
at the sub-transmural level, only those myocardial sectors which immediately
surrounded the location of the crystals were used. This typically meant that
five total sectors were used: (1) at the crystal (2) above and (3) below the
crystal and to the (4) right (5) and left of the crystal.
Metabolic Data Processing

20
Using the temporally paired blood samples from the coronary sinus and
femoral artery, the % saturation of hemoglobin (Hb) was determined using a
hemoximeter (OSM2 Hemoximeter, Radiometer Copenhagen). The oxygen
content of each sample was calculated using the Hb concentration and the
constant 1.33 ml 02/gm hemoglobin. The differences in oxygen content were
then calculated between arterial and coronary sinus/AIV samples and
multiplied by regional flow (taken form the five sectors described above) to
measure the regional oxygen consumption (MVO2).
Experimental Protocol: Normal response to dobutamine

Graded Dobutamine(ug/kg/min)
Baseline

|2.5|

^0

^ 7.5 ^

1M

15^

< PostD

C

ii

uS #1
MV02

uS #2
MV02

uS #3
MV02

uS #4 uS#5
MV02 MV02

uS=Microsphere injection for flow
MV02=Blood sampling for oxygen
content

A)

A 30-45 minute baseline period with injection of the first
microsphere for regional flow determination.

B)

Dobutamine, obtained as a stock solution (Dobutrex ®, Lilly) of 250
mg/20 ml (12.5 mg/ml) was diluted using sterile saline and injected
into the left foreleg brachial vein using a digitally calibrated
screw infusion pump to achieve precise infusion rates.

C)

Graded dobutamine infusions were done @>2.5 ug/kg/min (D2.5) for
10 minutes, @5.0 ug/kg/min (D5.0) for 15 minutes with injection of
second microsphere for regional flow, @>7.5 ug/kg/min(D7.5) for 10
minutes, @> 10 ug/kg/min(Dl0.0) for 15 minutes with the third
microsphere for regional flow determination, and @>15 ug/kg/min
(D15.0) with injection of the fourth microsphere for flow.

D)

A 15-30 minute period of observation after dobutamine (Post D) was
concluded was used to monitor recovery and assess myocardial flow
with the fifth microsphere injection.
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E)

The animals were sacrificed using a bolus of 2M KCL with
subsequent excision of the heart. The heart was then prepared for
gamma well counting as described above.

The following data (unless otherwise specified) was collected at 5 minute
intervals during baseline, twice at each level of graded dobutamine and at two
points during the 15 minute post dobutamine period.
(1)

Hemodynamic measures: Heart rate, mean aortic pressure,
right and left atrial pressure, left ventricular pressure with
its first derivative (dP/dt), LAD Doppler flow, and cardiac output .

(2)

Thickening data: Thickening and range data were obtained
at the Tm position at the intervals specified above. In
addition, thickening and range data was obtained at the Out 2/3 and
Out 1/3 positions twice during baseline, once at each level of
dobutamine and twice during the post dobutamine period.

(3)

Metabolic measures: Blood samples for oxygen content were
temporally paired to the determination of regional blood flow with
radioactive microspheres.

(4)

Arterial blood gas (ABG): ABG's were determined at intervals of 4560 minutes throughout the experiment.

Derived Data
In addition to the hemodynamic parameters mentioned above, two
additional hemodynamic indices were computed. (1) The pressure-rate (P-R)
product defined as the product of peak aortic pressure and heart rate expressed
as mmHg x beats/min. (2) The systemic vascular resistance was also calculated
using the following:
SVR = {{MAP- RAP) x 80) / CO (equation 10)
Where MAP = mean aortic pressure, RAP = right atrial pressure and CO =
cardiac output.

Data Processing for Pressure-Thickening Loops
All data processing was performed using Microsoft Excel® on the 486 25
MHz computer described earlier.

Microsoft Excel® is a spreadsheet program

which allows large amounts of data to be manipulated and plotted. The X-Y
graphic plots of left ventricular pressure vs. thickening used to create the
pressure-thickening loops were all generated using this program. The

following is a narrative description of the steps involved in processing of the
data.
A. The raw hemodynamic data derived from Dataflow® consisted of the
1500 data points with an average of 6-9 complete cardiac cycles. This
data was first downloaded into Excel® in the form a worksheet. Data
analysis was restricted to the LAD and LCX thickening data and left
ventricular pressure (LVP). Using Excel®, a automated program (i.e.
a "macro") was written to calculate dP/dt for all 1500 data points
using the following equation:
dP/dt(mmHg / sec) = (LVPx+l - LVPx)/(time x+l -timex)(equation 11)
Where x = an arbitrary point in time within the data file.
B. The thickening signal was first displayed using Excel® to ensure
signal quality. Five full cardiac cycles were then selected based on
the dP/dt using the point of initial upstroke as the onset of systole
and the point immediately preceding the next initial upstroke as the
end of diastole. In cases where five beats could not be used due to
either insufficient number of beats per data set or compromised
signal quality, the maximum number of possible beats were utilized.
C.

The data contained within these five intervals for LADTH, LVP and
LCXTH was copied to a new Excel® worksheet where it was rearranged
into columns of thickening and pressure data for each of the
selected beats using another macro written for this purpose.

D. Each of the separate thickening signals was then normalized to the
minimum thickening value for each beat. Thus expressing each beat
as a net excursion from its minimum value. This step was necessary
to compensate for the variable position of the signals along the
thickening axis. As discussed earlier, since the thickening signal
position bears no relation to the actual thickness, the loops obtained
prior to normalization could be centered on virtually any value. By
normalizing, all loops were based on a zero point for consistency.
D. The average values for five normalized beats were then taken for
LADTH, LCXTH, and LVP. dP/dt was re-computed based on the average
LVP for the five beats and time interval between the data points.
E.

X-Y plots were then made using Excel® for mean LADTH vs. mean LVP
and for mean LCXTH vs. mean LVP to generate the pressure
thickening loops, each representing the average of the five

,
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averaged cardiac cycles.(See Figure 6)

This process was repeated for

each manual save, including those with data for transmural, outer
2/3 and outer 1/3 thickening during the course of each experiment.
F.

The net systolic excursion was then calculated by taking the
difference between the maximum and minimum thickening value
during the systolic interval (where systole is defined by the initial
upstroke of dP/dt to peak negative dP/dt) for each of the normalized
beats. The average systolic excursion was then calculated for both
the LADTH and LCXTH.

G. By using the average systolic excursion and Doppler range obtained
from the original data file, the thickening fraction was then
calculated using the formula (equation 8) derived by Hartley.
H. To calculate sub-transmural thickening fractions, the difference in
systolic excursions was then taken such that Endocardial (Endo) =
(Transmural)-(Outer 2/3); Midwall (Mw) = (Outer 2/3)-(Outer 1/3)
and Epicardial (Epi) = Outer 1/3. The respective differences in the
ranges were used in equation 8 to generate the respective %TF for
each sub-region.
I.

Each of the pressure-thickening loops which was generated was
then planimetered three times using a SummaSketch®
(Summagraphics) digital planimeter pad then averaged. The area of
the loop was expressed in the square number of digital pixels
occupied by the loop on the planimeter pad.

J.

Similar to the approach to obtain transmural thickening data,
differences in measured areas were then computed to generate the
net area values for the Endo, Mw and Epi sub-regions.

Laboratory Responsibilities
All surgical responsibilities were divided among this investigator,
Jonathon Alderman and QingXin Shi. Dr. Albert Sinusas was responsible for
placement of the coronary sinus venous catheter and assistance with any
technical problems encountered during the course of the experiment. Dr.
Lawrence Young was responsible for processing of all metabolic blood
samples. All data analysis, with the exception of operation of the gamma well
counter and subsequent computation of regional blood flow, was performed by
this investigator.
Statistical Analysis
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All statistics were performed using Statview® 512, a statistical and
graphics program for the Macintosh computers. Correlations were expressed
as the Pearson (r) correlation. Statistical significance (at least p < .05) was
determined using a standard significance table with the appropriate degrees
of freedom [80],

Results
A total of seven dogs were used for this study. Two of these animals were
subsequently excluded from the data set: one secondary to a malfunction of
the Millar® pressure catheter and the other for technical complications
related to the surgical preparation. Of the five remaining animals, complete
data sets are available for three animals. The other two animals lacked either
complete metabolic or flow data sets. In addition, thickening and loop data
from the LCX region needed to be excluded for one animal secondary to poor
signal quality.
Hemodvnamics(Table 1)
Summarized in Table 1 are the hemodynamic parameters during the
experimental protocol. The heart rate, R-P product, maximal value of dP/dt,
cardiac output and LAD flow as measured with the Doppler flow probe steadily
increased with graded dobutamine dose. These hemodynamic parameters
generally returned to values intermediate to those of the baseline and D5.0
when dobutamine was discontinued. The mean aortic pressure (mean AoP)
responded differently with an initial increase up to D5.0 after which the mean
pressure actually declined slightly with further increases in dobutamine. The
mean AoP then returned to baseline 15 minutes after dobutamine was stopped.
To further examine changes in the vascular tone during these studies, the
systemic vascular resistance (SVR) was calculated.

With graded dobutamine,

the SVR steadily declined, from a value of 3708 +/- 242 at baseline to 1989 +/281 at D15.0.
Regional Microsohere Blood Flow (Table 2)
The regional blood flow at the Endo, Mw, Epi and Tm levels for both the
LAD and LCX region are reported in Table 2. Throughout the study, the flow
across the wall in both perfusion territories behaved identically with
increasing dobutamine producing parallel increases in flow. In the post
dobutamine period, however, flow decreased but failed to return to baseline
levels. Potential explanations for this observation are offered below.
Thickening Data (Table 3)
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A representative baseline LAD tracing of the thickening signals
obtained at the Tm, Out 2/3 and Out 1/3 sampling locations are shown
superimposed in Figure 7 to demonstrate how thickening increased
progressively as the Doppler range was advanced from the epicardium towards
the endocardium.
The data for the LAD and LCX territories at both the transmural and sub¬
transmural levels are summarized in Table 3. The %TF at all levels was found to
initially increase with dobutamine, then plateau as dobutamine increased. The
thickening fraction returned to baseline levels once dobutamine was stopped.
The %TF for the Endo, Mw and Epi exhibited a transmural gradient
favoring the deeper myocardial layers in both territories throughout the
experiment. With graded dobutamine, the %TF for the Endo and Mw tended to
equalize in both the LAD and LCX regions, while consistently remaining
higher than the %TF for the epicardium.

Pressure-Thickeninfi Loop Area (Table 4)
Sub-transmural work was estimated by analysis of the pressure¬
thickening loop areas. The changes in these loop areas for both the LAD and
LCX regions are summarized in Table 4. A typical LAD Tm (full wall thickness)
pressure-thickening (P-T) loop at peak dobutamine is illustrated in Figure 6 .
All area measurements of P-T loop areas are expressed in units of square pixels
occupied on the digital planimeter pad described earlier.
There was a different response in the loop areas to dobutamine in the
LAD and LCX regions. With graded dobutamine, the LAD Tm loop area, and
therefore work, progressively increased with each level of dobutamine while
the LCX Tm work plateaus after D 2.5. Further sub-transmural analysis
demonstrated that: (1) Dobutamine greatly increased work when compared to
baseline although in a nonlinear manner. (2) At all times, the work performed
by the Endo and Mw was greater than that performed by the Epi. (3) At 15
minutes after dobutamine, work declined although did not return to predobutamine levels in all animals.
Metabolic Data
The regional oxygen consumption (MV02)(ml 02/min/100 gm) for the
LAD perfusion territory was calculated as a independent metabolic measure of
regional work. With graded dobutamine the MV02 increased steadily from
10.65 +/- 2.35 at baseline, to 11.18 +/- 1.03 at D5.0, 1 1.52 +/- 0.87 at D10.0, and
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13.25 +/- 0.77 at D15.0. With the cessation of dobutamine, the MV02 declined
towards baseline to a value of 9.20 +/- 0.80.
Loop Areas and Indices of Myocardial Work (Table 5)

To evaluate the use of the P-T loop as an index of work, correlations
were sought between the Tm loop area in the LAD and LCX region and either
the MVO2 (LAD only), R-P Product, or maximal dP/dt. All data points were
expressed as a % change from baseline in order to facilitate the incorporation
of multiple animals into the same data set. These three variables were used to
compare the P-T loop to both regional (MVO2) and global (R-P product and
maximal dP/dt) indices of work. As seen in Table 5, a fair (r=.524)(p<.05)
correlation exists between the LAD Tm loop area and regional MVO2 (Figure 8
a) . Comparisons between the Tm loop area and the hemodynamic indices of
work revealed significant correlations between the LAD Tm loop area and both
the P-R Product (r=.648)(p<.01) and max. dP/dt (r=.8 14)(p<.0 1 XFigures 8 b-c).
Equally significant correlations were found between the LCX Tm Loop area and
max. dP/dt (r=.822)(p<.0 1) and P-R Product (r=.9 17)(p<.0 1 XFigures 9 a-b).
Blood Flow Relations to Loop Area and Indices of Work: (Table 5)
The relationship between both LAD and LCX transmural flow was then
compared, after normalization baseline as before, to the same three markers of
function as above. In each case, there an excellent correlation found to exist
between the LAD transmural blood flow with either the (1) MVO2
(r=.886)(p<.01) (2) P-R Product (r=.9 12)(p<.0 1) or the (3) max. dP/dt
(r2=.863)(p<.0 1 XFigures 10 a-c) and LCX transmural blood flow with both the
(1) P-R product (r=.90 1 )(p<.0 1) and (2) max. dP/dt (r=.871 )(p<.01 XFigures 11 ab) .

Transmural flow was also related to the area of the P-T loop area with

significant correlations being demonstrated for the LAD (r=.633)(p<.05)(Figure
10 d) and LCX (r=.879)(p<.0 1 XFigure 11 c) territories.
To evaluate the P-T loop area as an index of change in sub-transmural
work, comparisons were sought between microsphere flow and loop area at the
Endo, Mw and Epi levels for both the LAD and LCX territory. Microsphere flow
was used as the comparative index of work based on (1) the strong correlations
noted between the transmural flow and both metabolic and hemodynamic
indices of work and (2) the lack of appropriate metabolic and hemodynamic
indices of work at the sub-transmural level. As shown in Table 5 and Figures
12 a-c, for the LAD territory, significant correlations between microsphere
flow and loop area were noted only for the midwall and epicardial sub-regions,
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with a non-significant positive correlation noted for the endocardial subregions: endocardium (r=.256)(p=NS); midwall (r=.572)(p<.05); epicardium
(r=.68 1 )(p<.01). In contrast, Table 5 and Figures 13 a-c demonstrate that for the
LCX territory, significant correlations were noted only in the endocardial and
epicardial sub-regions, with a non-significant positive correlation found for
the midwall sub-region: endocardium (r=.9 17)(p<.0 1); midwall (r=.523)(p=NS);
epicardium (r=.766)(p<.0 1).
Discussion
In this study, we have demonstrated that analysis of regional left
ventricular pressure-thickening loops holds promise as a reliable index of
changes in cardiac work. These loops were generated using a new Doppler
based epicardial thickening crystal which provided for the ability to
discretely sample the thickening at the level of the endocardium, midwall and
epicardium. The transmural loop area was found to correlate significantly
with transmural myocardial blood flow, MV02 and accepted hemodynamic
indices of global myocardial work. In addition, strong positive correlations
were found between the transmural flow and these same indices of work
supporting the use of flow as an indirect index of work at the sub-transmural
level. Finally, the Endo, Mw and Epi P-T loop areas were examined with respect
to their sub-transmural blood flow where in general, significant correlations
were noted. It is therefore the conclusion of this thesis that the left
ventricular pressure-thickening loop may prove, with further analysis, to be
a reliable index of changes in regional work at a level of analysis not
previously available.
Loop

Area Analyses

with

Comparisons to Indices

of

Work

Suga has extensively studied the use of the pressure-volume loop area
(PVA) as an index of cardiac work by relating it to myocardial oxygen
consumption [67, 69], The correlation reported between these variables was
higher (r^=.98) than that reported in this study (r2=.274). One potential
explanation for this discrepancy is that the model used by Suga, in contrast to
that used here, was that of an ex vivo canine-excised, cross-circulated heart
where pressures and volumes could be precisely controlled. A second possible
explanation lies in the fact that the pressure-volume analysis is by definition,
a more global assessment of work than the P-T loops generated in this project.
It is possible that the MVO2 and work at the regional level ( i.e. using the
pressure-thickening analysis) may show local heterogeneity, the details of

which could be masked in measuring these variables at the global level (i.e.
the pressure-volume analysis).
Recent work by Starling took the PVA analysis one step further by
examining whether the use the PVA improves upon other hemodynamic based
measures of myocardial work. Of relevance to this project was the finding that
both the PVA and P-R product had a similar correlation to the MVO2. Thus, it
was concluded that the PVA did not improve on the other indices of myocardial
work [70]. The relative importance of this type of global analysis using the
PVA was thus called into question since it fails to provide more useful
information than methods clinically available (e.g. calculation of P-R
product).
Other investigators have approached the measurement of segmental
myocardial work from a more regional level using the pressure-length (P-L)
loop. Forrester et al. found a linear relationship between the area of the P-L
loop and the stroke work suggesting that the area circumscribed within this
loop was a valid index of segmental performance [8 1 ]. This type of validation
was limited in that comparisons of work at the regional level were made to
more global indices of cardiac function (i.e. the stroke work) [751.
Recent work by Vinten-Johansen compared the pressure-length loop
area at the transmural level to both segment shortening and regional MVO2
after repetitive occlusion-reperfusion periods in the dog. This study was one of
the first to quantitatively compare the P-L loop area to a metabolic index of
regional work. The authors noted a strong positive correlation between the
stroke work ( i.e. P-L loop area) and regional MVO2, both of which remained
elevated in the face of dyskinesis and/or akinesis in the involved segment.
The study, therefore, came to the conclusion that continued segmental work
was partially responsible for previously noted discrepancies between segment
shortening and regional MVO2 . While the goal of this study was not a
validation of the P-L loop as an index of regional work, the good correlation
with regional MVO2 partially supports this hypothesis.
This thesis improves upon these earlier attempts using the pressurelength loop, by validating the use of the pressure-thickening loop against
three independent markers of myocardial work. The first index to which the
P-T loop was compared was the myocardial oxygen consumption (MVO2). The
MVO2 has been shown to be linearly related to the inotropic state of the heart
[82]. The findings in this thesis that the MVO2 steadily increased with graded
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dobutamine are in agreement with these earlier observations. This is not
surprising based upon the strong

properties of dobutamine which increase

cardiac work through inotropic and, to a lesser extent, chronotropic effects
[22]. The strong interrelation between cardiac work and the MVO2 has made
this index a "gold standard" for comparison for other indices of work.
The other two indices of work used for comparison in this study are
related to the hemodynamic performance of the heart. First, the pressurerate product depends on changes in both heart rate and systolic arterial
pressure, both of which have been shown to positively contribute to oxygen
consumption and therefore cardiac work [831. Concern regarding the use of
the P-R product to estimate the MVO2 and therefore work in a canine model
using halothane anesthesia was addressed by Rooke. He was able to
demonstrate that the P-R product was indeed a valid index of estimation of
myocardial work despite halothane anesthesia [84]. The third index utilized in
this study was the maximal value of the first derivative of left ventricular
pressure with respect to time. Again, this index was also found to linearly
relate to oxygen consumption and work [82]. Based on these findings, we felt
that the excellent correlations noted between the P-T loop area at the
transmural level and these indices of work provided an empirical validation of
our approach to regional work.
As alluded to earlier, the lack of both hemodynamic and metabolic
information at the sub-transmural level led to the use of flow as the basis of
comparison for the sub-transmural P-T loop areas. The significant
correlations found at the transmural level between flow and the MVO2, P-R
product and maximal dP/dt indicate that in this preparation, flow behaved as
an approximate index of work for comparison to the P-T loop areas.
Regional Differences in

Loop

Area

vs.

Flow Correlations

At the sub-transmural level of analysis we noted an inconsistent
pattern of correlations between microsphere determined blood flow and
respective loop area. Specifically, microsphere flow and loop area failed to
reach statistical significance for the endocardium in the LAD and the midwall
in the LCX territory. The most likely explanation for these unexpected
findings relate to statistical uncertainty associated with the small sample size.
Numerous authors have shown that, under pathologic conditions, flow
and thickening correlate best in the deeper myocardial layers , especially the
endocardium. Under normal conditions however, one finds that flow and

thickening correlate in both superficial and deeper myocardial layers. This is
true under a variety of experimental conditions including ischemia, exercise
and atrial-paced tachycardia [61-64,87,931. One would therefore expect that the
pressure-thickening loop area, being derived from thickening data, would
show the same relationship to flow. We are optimistic that with additional
studies, this relationship will indeed hold true.
Regional Differences in Changes in

Loop

Area With Dobutamine

The results of this study would seem to indicate a different response to
dobutamine between the LAD and LCX territories with respect to changes in
the pressure-thickening loop areas. A priori, there would be no reason to
expect a different response in one bed versus the other as both were studied
under the same conditions. One explanation for this observation again lies in
the small sample size used here. It is therefore possible, and to be expected,
that with augmentation of study numbers, the observed responses to
dobutamine would equalize.
A second potential explanation could be that there were subtle
differences in signal quality between the LAD and LCX territories. Since the
LAD and LCX pressure-thickening loops are generated using the same intra¬
ventricular pressure, any difference in signal quality could adversely affect
the quality, and therefore the area of the loops. As the LCX Doppler crystal
occasionally lies close the pericardial cradle, movement of the pericardium
against the crystal may affect signal quality in that region. Any difference
inherent to signal quality between the LAD and LCX regions should be borne
out as more experiments are performed.
A third potential explanation may lie in the placement of the crystals on
the epicardial surface of the left ventricle. The LCX crystal tends to be placed
in a more basal position relative to the LAD crystal to avoid placement of the
LCX crystal over a papillary muscle. There may be as yet undefined
differences in contractile reserve between these crystal locations which could
limit changes in the loop area with inotropic stimulation.
Regional Function Analysis
The use of the Doppler based method to assess myocardial thickening
has several importance advantages when compared to the standard two-crystal
transit time technique. To elaborate on those eluded to in the introduction,
each will now be addressed separately.
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The Doppler technique is less traumatic to the myocardium since each
crystal is sutured only to the epicardium using a few sutures penetrating 0.51.0 mm into the wall. In contrast, implantation of the ultrasonic crystals
requires a stab wound into the ventricle through which the crystal is
tunneled into the wall. The crystal occupies a 2 mm3 space within the wall
producing both edema at the stab wound and secondary distortion of the local
fibers. The effects of this distortion are impossible to quantitate and may
adversely affect the accurate measurement of segment length and thickening.
The second and related advantage of the single crystal Doppler
technique is that its proper function is affected less by changes in fiber
orientation across the myocardial wall.

The Doppler crystal directs its sound

waves perpendicular to the myocardial wall, so changes in the fiber
orientation across the wall should not affect the reflection of the sound pulse
back to the probe. It has been shown that the myocardial fibers vary in
orientation by about 1 10” from epicardium to endocardium [851. In order for
the ultrasonic crystals to correctly assess changes in segment length they
need to be positioned along the same shortening axis [86], Since the positions
of the crystals can only be documented post-mortem, it is impossible to be
confident of the crystal position during any given study.
Furthermore, when the ultrasonic technique is employed to measure
transmural wall thickening, the crystal within the myocardial wall is subject
to the rotational effects of contraction which may displace the orientation of
the crystals and adversely affect signal quality. While the Doppler crystal
signal may be affected by the same rotational effects, it is unlikely that the
Doppler signal would be affected to the same degree [42]
The third and most significant advantage of the Doppler crystal
technique lies in its unique ability to sample thickening at various levels
across the myocardial wall at the same location. The amplitude of the
thickening signals obtained in this thesis were found to be proportional to the
position of the range gated sample volume. This is in good agreement with
previous reports using the same technique [451
Transmural Thickening Relations
The transmural pattern of the calculated sub-transmural thickening
fractions at baseline demonstrated a gradient favoring the endocardium, also
in agreement with previous investigations [16, 44, 48-50], The finding that the
%TF in the Endo and Mw tended to equalize with dobutamine has not been
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previously reported using the Doppler crystal technique. A related study by
Gallagher using the transit time technique examined how the inner 1/2 and
outer 1/2 (of the wall) %TF changed with exercise. The results of that study
indicated that the gradient in thickening function remained constant with
exercise, always favoring the endocardium [87], The obvious difference
between that study and this thesis is how the myocardial wall was divided for
analysis. While the relationship between the Endo and Mw %TF was blurred
during dobutamine in this study, the %TF for either of these was always
greater than that in the Epi, supporting the constancy of the thickening
gradient despite changes in myocardial performance.
Hemodynamic effects of graded dobutamine
In contrast to observations by other authors, we noted a much more
dramatic response in the heart rate with graded dobutamine. Vatner reported
that up to 40 ug/kg/min in a canine model that the heart rate increased 142%
while we noted a 170% increase with a dose of only 15 ug/kg/min [88], A
potential explanation lies in the fact that pentobarbital anesthesia as employed
by Vatner et al. has potent myocardial depressant properties (89], Therefore,
the heart rate response to dobutamine might have been blunted in comparison
to that seen in this thesis where halothane anesthesia was employed.
The response of the systemic vasculature observed in this study is in
full accord with the literature. Dobutamine is known to stimulate both

ax -

receptors in the vasculature [22]. These effects are felt to be relatively
balanced resulting in little direct vascular effects. In this thesis, at the lower
doses of dobutamine, mean AoP rose modestly (20%) then steadily declined as
the level of dobutamine increased. The initial increase in systemic pressure
was most likely related to the augmented inotropic state of the heart as
evidenced by the early and pronounced increase in dP/dt (167% increase at
D2.5 compared to baseline) and cardiac output (127% over baseline at D2.5)
resulting in the higher systemic pressure. As the dose of dobutamine
increased however, there was most likely a reflex withdrawal of sympathetic
tone which resulted in a decrease in the vascular resistance (a 49% decline at
D15.0 compared to baseline) and thus systemic arterial pressure.
Dobutamine effects on the coronary circulation
Dobutamine is also known to have effects on the canine coronary
vasculature. We found a steady increase in Doppler epicardial LAD flow with
graded dobutamine. This agrees with findings by other investigators that

and
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epicardial coronary blood flow increases in parallel to demand with secondary
coronary vasodilatation and decreased coronary resistance [90], Dobutamine
was shown in this thesis to have produced a marked increase in myocardial
contractile performance and therefore demand, thus explaining the
significant increases in observed flow.
At the sub-transmural level, we found that flow increased at all levels
throughout graded dobutamine infusion with a gradient of flow favoring the
epicardium in both perfusion territories. This gradient of flow is in contrast
to that usually reported. Hoffman proposed after reviewing a number of
experimental studies that the transmural gradient of flow was usually most
altered in those models with an elaborate surgical preparation such as that
used in this thesis [51]. The reasons for this are unclear, but may relate to
changes in vagal tone and the use of halothane anesthesia. Vatner
demonstrated that halothane (1 %) had a tendency to dilate the epicardial
coronary vasculature. This tendency was partially offset by the cardiac
depressant effects of halothane which tended to produce a decrease in
metabolic demand, and therefore constrict the coronary bed [91].

Since flow

reserve is known to be less in the subendocardium than the subepicardium,
the combined effects of halothane could operate to produce the gradient of
flow favoring the epicardium observed in this study.
We noted in the post-dobutamine period that flow declined towards, but
failed to return to, baseline values. While the half-life of intravenous
dobutamine in humans is known to be about two minutes [22], no information
is available regarding the half-life of the drug in dogs. It is therefore possible
that the effects of dobutamine may persist beyond the time we expected and
augmented flow and function 15 minutes (i.e. at the time of data collection)
after maximal dobutamine had been terminated. Support for this theory could
be taken from the fact that the heart rate, pressure-rate product, dP/dt, and
cardiac output all behaved in a similar manner, failing to return to baseline
after dobutamine was discontinued. It is also possible that the observations
made here are an artifact of the small number of animals used for this study.
Study Limitations
Several potential sources of error may have adversely affected both data
collection and analysis during the course of this project. The first and most
important limitation of this thesis is the small number of experimental
animals enrolled in the study. While pressure-thickening loop analysis has
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been applied in more complex ischemic models in our laboratory, we chose a
simpler, non-ischemic model to preliminarily define the role of the pressure¬
thickening loop as an index of changes in regional myocardial work.
As this model depended on the use of anesthetized animals, any inter¬
animal differences could have accounted for the variability observed in the
hemodynamic, flow and thickening responses to dobutamine. In addition, the
use of in vivo models is frequently complicated by the need to exclude
experimental animals from analysis for various technical reasons. This study
was no exception with only 70% ( 5 of 7 ) of the animals originally enrolled in
the study being included in the final data set.
A limitation regarding the type of anesthesia used in this study lay in
our inability to accurately measure the end-tidal concentration of halothane
due to lack of equipment. This may have resulted in slightly different depths
of anesthesia among the animals. While halothane is a known myocardial
depressant, it has been shown that the most deleterious effects are not
observed until an end-tidal concentration of 2% is reached [9 1 ]. The
halothane concentration in this study was kept at an inspired concentration
of 0.5-1.5%; if one assumes steady state conditions at the alveolar level, than it
is unlikely that the halothane used in this study produced significant
hemodynamic effects.
With reference to the collection of the thickening data, Zhu et al.
examined how the position of the range gated sample volume with reference to
the true end-diastolic depth affected the %TF measurement. They were able to
show that errors of 1 mm in either direction did not produce appreciable
artifacts when validated in the two-crystal setup described in the introduction
of this thesis [44].
An additional source of error which could not be easily controlled for
was the signal quality obtained with the Doppler crystal. Most of this error
was observed with the crystal located in the LCX territory, as evidenced by the
need to exclude this data from one of the animals used in this study. While at
post-mortem analysis, no crystal was noted to be situated over a papillary
muscle, it was occasionally found that the crystal was at or near the edge of
one. Since the papillary muscle produces a tangential force on the
endocardial surface during its function, crystals which sample thickening
near the insertion point could have artifacts related to the papillary muscle

■
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function. This was rarely an issue in the LAD territory due the more basal and
lateral position of the papillary muscles relative to the anterior wall.
A methodologic limitation of the Doppler technique which was
described earlier is the difficulty in quantifying the absolute left ventricular
wall thickness. For the P-T loop analysis used here, this was not a problem
since only the relative change in thickening (i.e. thickening excursion) was
used to generate the loops. This inability to report true dimensions limits the
application of real-world units of work to the area of the P-T loops. The loop
area thus can only serve as a relative index of work, and not an absolute
measure. The wall thickness could be estimated using the value of the range
gate delay at which the blood pool was detected; however, this point would be
difficult to consistently measure. This issue has recently been addressed with
a new thickening module (Crystal Biotech, Holliston MA) which is able to
reliably track the endocardial (or any other) point to give an accurate
measure in millimeters of wall thickness.
Several lines of investigation have evaluated the gradient of pressure
across the myocardial wall [95-98] . While not conclusive, most studies have
shown that a pressure gradient exists favoring the endocardium. If true,
concern regarding the assumption of constant transmural intra-myocardial
pressure inherent to this thesis could be raised. No attempts to quantitate
intra-myocardial pressure were made during the course of this study due to
the difficult and unreliable technical methods currently available for this
purpose. If, however, one assumes that the gradient of pressure exists, then
corresponding reductions would need to be made in the measured P-T loop area
to compensate for the reduced pressure at the Endo, Mw and Epi sub-regions
compared to the LVP as measured with the Millar® catheter located within the
left ventricular cavity.
A final methodologic limitation of this study is related to the
determination of myocardial blood flow using the radiolabeled microsphere
technique. Buckberg et al. summarized the potential errors associated with
this technique and came to the conclusion that the error was minimized if (1)
more than 400 microspheres were in each sample counted for flow (2) the
microspheres were injected into the left atrium to ensure an even distribution
in the bloodstream and (3) the microsphere technique was used in the dog.
Since the microspheres are known to evenly distribute according to blood flow
and at least 2 million microspheres were injected into the left atrium in this
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canine model, then assuming that the heart receives 4% of its cardiac output
we estimate that each of the 96 myocardial samples contained >400
microspheres, well above the level established by Buckberg for accuracy [92],
Future Applications
This preliminary validation of the use of the pressure-thickening loop
as an index of sub-transmural work supports further testing of this approach
in other animal models. As stated earlier, we have applied this approach in
two other model systems as part of pilot studies. We first applied it in a canine
model of myocardial stunning (n=2) produced by a 15 minute complete
occlusion of the LAD with three hours of reperfusion. The use of the P-T loop
in this setting showed promise as a means to track the temporal sequence of
functional recovery and its modification with dobutamine. We also applied
this technique in a model of critical coronary stenosis (n=2) with dobutamine
stimulation in an effort to obtain a better understanding of the flow-function
relationship in the presence of a non flow-limiting stenoses.
One aspect of the P-T loop which was not specifically addressed in this
thesis was the change in loop morphology with dobutamine. We look forward
to defining characteristic "loop responses" in shape as more data is collected
on other animals since the limited number of animals in this study did not lend
itself to this type of analysis. In addition, the P-T loop was not specifically
analyzed with respect to the temporal sequence of contraction at the sub¬
transmural level. By superimposing temporally paired Endo, Mw and Epi loops
on the same axes, it should be possible to examine the sequence of contraction
across the myocardial wall. This analysis could also be applied to the raw
thickening signal itself to obtain similar information.
While this thesis looked primarily at indices of systolic function and
work, the pressure-thickening loop has the potential to provide useful
information on diastolic function as well. The diastolic segment of the loop
could easily be analyzed with respect to temporal parameters of diastolic
thinning such as (1) the mean rate to one-half end-diastolic thinning and (2)
the late-diastolic thinning fraction. These type of analyses could provide
important information regarding diastolic dysfunction and its modification
with inotropic agents.

Clinical Applications
A recent paper by Bolli et al. reported on the use of a modified Doppler
thickening crystal on humans undergoing coronary artery bypass graft
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surgery. This crystal was attached to a suction cup which was then positioned
on the cardiac surface to measure the thickening fraction before and after
surgery. This allowed the investigators to monitor functional recovery across
the myocardial wall after revascularization [47], The success of this
application raises the possibility of generating P-T loops in the clinical setting
during similar open chest procedures to monitor cardiac function and assess
interventions aimed at maximizing function.

Summary
In this thesis, I have applied the use of a Doppler thickening crystal to
generate sub-transmural left ventricular pressure-thickening loops which
were first compared to independent indices of cardiac work and flow at the
transmural level, then with flow at the level of the endocardium, midwall and
epicardium with good results. The results of this analysis lend support to the
use of these loops as a new index of regional work which provides information
at a level of detail not available with other techniques. Future directions and
potential clinical applications of this technique were outlined as well as the
limitations of this approach. This type of approach will ultimately further the
understanding of the complex interrelationship between myocardial flow,
function and metabolism central to the management of patients with coronary
artery disease and its complications.

38

Tables 1-2

o

\c

x

r-

r-

E x
3

—

t5 reu c+
k_

'a _

re
*
■o

i r‘
h u +

00

+ +
sc o

t: 2

S

+

E

sCT>
c

reu
o

"D

x e
(_) LU

E

IJia
y
is
(M

TABLE 1

Hemodynamics (All values +/- SEM)

3

+

+

+

+

+

X
o

X
r-

—
■«£

'r.
C

x
r-

E 'A cr 'A

D — ^ T

c o
+ +
re +
u - x
c rr,
L' -f
•A
X
Q.

— ON —
CD

- ®
n

<
--

c i

rl

—

r .

^.

—

X

—

»A

R S? £ 8

E

0?
S I

.2 -• 2
T>
o =
W.

f--.

a-

>
^

r j
n£

C
X

X
ri

3 ir;
3 0c
ir, o ir, 3
,r:
^
~
~
OOOOO-3E
3 3 3 3 C P
3 'P ■= •= 'P 3

O c 3 £ E C -3
C 3 3 3 3
P 3 p P P ~'
% X £ X £ .c £

—

L_I

5 C C C C C

zL

reu + +
q ■§ 5 U
< £
Q 3 ix,
,r

o
c
'3
o 3
c 3
^ D
x -£

~

o
c
'3
c
5
3
•£

~

o
c
’3
e
3
3
•£

c
£

P
P
3
£
^
—
S

39

17787+'- 2528
—

*r.
X

re

r-

£

*/.

— oc.O'

o

3

re

»r.

ri

rr;

ri

—

rere rere rere
re re re
xxx

x

re

ir o i/"> ^
i r.

—

o o o o

re re re re
v E E E E
c

re

re

re

re

FF re re re re
% x x x x

x C C X C,

6582+.'-884

4868+.'-962

11408+'- 1102

5066+-1568

4095+ - 5X5

[_I

o o

£
-3

Dobutamine 15.0
Posl Dobutamine

ir, o ir,i O ir. c
r^i «r r

1X57+'- 1255

59I0+.-39

O

T3
X c
CJ UJ

4798+- 2187

5259+.- 1258
-T

+ +
r-

4805+'- 1474

reU

TABLES 3-4

o
i
d
<
or

t—

X0IX + -II29

r^;

<
<

5200

E
D

220X5 + -I475

i±

I324X +

ll

5515 +■- 1002

ro

II501+/-49I5

Tables 3-4

Table ^

01
LO.—

TO

oooooooooooo

C

vvvvvvvvvvvv

V

Q.Q.Q.Q.Q.Q.O.Q.Q.Q.Q.Q.

Q.

U

LT>«—

Ln

r;

r-«—

° «/>

.

"5l
(75

P

2

V

V

CL

CL

"O
Si

re

CO o
f^ (X) (XI
C\J CD

o

o

o o o

00 ro
(XI rx
ro (XI

ro rx
<D CO

O 00

o o o o o

o o

O

o

o o

CO ro (XI rx oo <D ro (XJ T— r—
ro CXI r— rx CO CD »— rx o
(XI »—
LO °o <D <D 00 CD 00 00 CO CD 00 CD
d d d d d d d d d d d d

(D rx
(XJ CD

(XI ro
rx (XJ
LO LO

r— CD
CO CD
CD fx

d d

d d

d d

d d

ro LO
00
<D
ro LO i—
r- 00
NCD 00 rx ix fx 00 rx oo
O

(D
LO

LO

«—

LO

r\J

c

rnoororooococo^^^oooo

Table 5

Correlative Data Analysis

3
O’
tf)

•cTOTO

+->
(J

>

3
4-*
“O *D
O
"re X
CL CL
o “D
vd

>
c

CL

o

'CD
a;

(/)g

<U
n
re
•c
re
>
4-1
g

U_

(XJ
O

-O

CL

U_
4-* CU
(J
3 <U
-C 4-» “O -C
Q. T3 o Q.
CO cl k_ CO
CL
“O
CL
i
CL
1i<U

ka;

3

E

Q

<

re
<u

re<U

re
<U

E

r\j
o
>

TO

L_

<
CL
o
o
_)

<
Q.
O
O
_J

o X
cd
<;

CL

D

rea; re
<u

TOa) re
<D

< <
Q. QO O
O O
-J _l

< <
CL CL
o O
o o
_i —1

o

X

<

CD

Q X
CD
<:

X

u

recu re re re
(U <U <u

£
_o
Li¬

£
O
u_
a;
k_
<U
-C
CL
CO
3

$
_o
u_

$ £
o _o
Li_

$

$

$

_o _o

_0

o

Li_

Li_

U_

Li-

Li¬

Li-

<U

0)

a;

OJ

eu

OJ

o

Li_

< < < < < < < eu
<U a; CD
CL CL CL CL CL CL Cl iu
o3 <U <u
O o o O C O O -C
D
_c
O o o o o o o a
CL Cl CL
_1
_1
—1
—J
_J
_l
—J
CO
(O
re
(O CO
k.
3
3 3 3
3 Q Q a o X X X
C < < < < CD CD CD Q Q Q X X
c -J
_i _1 _1 _1 _1 < < < CD CD
(/>
—1 -J
_l
re

II-

TOa; re
a>

4—'
U
u
3
3
"D
“0
TO O T3 O
X
"to CL
CL CL CL
TO
o "D
CL
QC
CD
CL
+->

k.

eU
ai
JC _c
CL CL
CO CO
3
3

u

O

X

<
-J

CD
—1

E
3

re

o
“D
C
LU

<U
_c

CL
LO

3

re
■g
f

Q
<
—1

£

£

3

<U
<u
D _c
CL CL
CO CO

L.

O

X

o

<
_1

CD
_1

<V
_c
CL
CO

3
X
CD
_J

E

re

a
LU

3

3

41

Figure 1

Fieure 1: Schematic drawing of the P-V diagram of the left ventricle. P-V loop
is the tragectory of an ejecting contraction. The systolic segment (heavy
curve) of the trajectory starts at a point on the end-diastolic P-V relation
curve and ends at a point on the end-systolic P-V relation line.
The
rectangular area under the systolic segment of the P-V trajectory is
equivalent to the external mechanical work of the contraction. The triangular
area under the end-systolic P-V line between its volume intercept (Vd) and the
end-systolic P-V point is equivalent to the end-systolic potential energy. The
sum of these two areas is the pressure-volume area (PVA).

Figure 2

CONTROL

TO Itcond
ISCHEMIA

30 mimit*
ISCHEMIA

Figure 2: Instantaneous X-Y plots of left ventricular pressure vs. segmental
length (mm) as measured with a segment length gauge. From left to right are
pressure-length (P-L) loops under control, 10 seconds of ischemia and 30 min
of ischemia. (Adapted from Tyberg, 1974).
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Figure 3

Figure 3: Pressure-length loop obtained from the LAD territory during mild
ischemia.
End-diastole (ED), defined by the initial upstroke of the first
derivative of left ventricular pressure (dP/dt), and end-systole(ES) defined by
the return of aortic flow to zero are indicated by vertical lines. ES = effective
shortening area; PSS = post systolic shortening area; SL = systolic lengthening
area (adapted from Safwat, 1991).

Figure 4

ENDO

EPI

Figure 4: This schematic cut-away of a portion of the myocardial wall
demonstrates the use of the epicardial Doppler crystal to measure thickening
across the wall. The sample volume 0 is shown at three positions across the
wall, corresponding to outer 1/3 (a), outer 2/3 (b) and transmural (i.e. full
thickness) (c) thickening (reproduced with permission from Edwards, 1991).

Figure

*5:

Shown here is a typical screen display from the DATAFLOW® program showing the waveform
display at center; the various computed statistics for each channel at right; the trending file in
the lower left; and real-time pressure-thickening loops for both the LAD (left) and LCX (right) in
the lower right corner.
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Figure 5

44

Figure 6
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Figure 8 (a-c)

(a)

(c)

LAD Tm Area
( x 100%)

(b)

Figure 8 (a-c): Shown here are the scatter plots with their respective
correlations and significance levels for the LAD Transmural P-T loop area
(LAD Tm Area) vs. the MVO2 (a), maximal dP/dt (b)t and P-R product (c). All
data points are expressed as % change from baseline in order to facilitate
incorporation of multiple animals into the data set. Of particular note are the
good correlations observed between the Tm P-T loop area and the other
variables.

■
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Figure 9 (a-b)

(a)

(b)

Figure 9 (a-b): In this figure are shown the scatter plots with their
respective correlations and significance levels for the LCX transmural P-T loop
area (LCX Tm area) vs. the maximal dP/dt (a) and P-R product (b). All data
points are expressed as % change from baseline in order to facilitate
incorporation of multiple animals into the data set. Again, good correlations
were noted between the Tm loop area and hemodynamic indices of myocardial
work.

Figure 10 (a-d)

(a)

(c)

(b)

(d)

Figure 10 (a-d): In this figure, the scatter plots for the LAD transmural
microsphere flow (LAD Tm flow) vs. the MVO2 (a), maximal dP/dt (b), P-R
product (c), and Tm P-T loop area (LAD Tm Area) (d) are shown; again with
their respective correlations and significance levels. All data points are
expressed as % change from baseline in order to facilitate incorporation of
multiple animals into the data set. As seen above, flow at the transmural level
significantly correlated with both metabolic (MVO2) and hemodynamic
(maximal dP/dt and P-R product) indices of myocardial work in addition to the
P-T loop area. Flow thus appears to function as an indirect marker of work in
this animal preparation.

Figure J1 (a-c)

(b)

Similar to Figure 10 above, this figure depicts the scatter
plots for the LCX transmural microsphere flow (LCX Tm flow) vs. the maximal
dP/dt (a), P-R product (b) and Tm P-T loop area (c). Once again, significant
correlations were found in all cases. As the M VO2 was only measured in the
LAD territory, this metabolic index of work was not used for comparison to the
LCX Tm flow. All data points are expressed as % change from baseline in order
to facilitate incorporation of multiple animals into the data set.

Figure 12 (a-c)

(c)

LAD Endo Flow
( x 100%)

(b)

Figure 12 (a-c): In this figure, the respective sub-transmural (i.e.
endocardial (a), midwall (b), and epicardial (c)) microsphere flows and P-T
loop areas are compared for the LAD territory. While positive correlations
were noted in all cases, statistical significance was only achieved for the
midwall and epicardial sub-regions. All data points are expressed as % change
from baseline in order to facilitate incorporation of multiple animals into the
data set.
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Figure 13 (a-c)

(a)

(c)

LCX Endo Flow
( x 100%)

(b)

In this figure, the respective LCX territory sub-transmural
(i.e. endocardial (a), midwall (b), and epicardial (c)) microsphere flows and PT loop areas are compared. While positive correlations were again noted in all
cases, in this case statistical significance was only achieved for the
endocardial and epicardial sub-regions. All data points are expressed as %
change from baseline in order to facilitate incorporation of multiple animals
into the data set.
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